Ticker Scorecard - ABEO Basics Company: Abeona Therapeutics Inc. IPO Date: November 9, 1984 Sector: Healthcare Industry: Biotech Market Cap: $254.74M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.64% Avg Daily Range (30 D): $0.10 | 1.83% Avg Daily Range (90 D): $0.12 | 1.91% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .25M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 32 Avg Trade Size (Sh.) (30 D): 97 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 356 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $.62M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $3.51M Avg Closing Trade (90 D): $3.51M Avg Closing Volume: 14.61K     News Jan 2, 2025 @ 7:30 AM Global Mucopolysaccharidosis Treatment Market to W... Source: Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.) Jun 3, 2024 @ 11:30 AM Abeona Therapeutics Announces New Employee Inducem... Source: Abeona Therapeutics Inc. May 28, 2024 @ 11:30 AM Abeona Therapeutics to Present at the Jefferies Gl... Source: Abeona Therapeutics Inc. May 15, 2024 @ 11:30 AM Abeona Therapeutics Reports First Quarter 2024 Fin... Source: Abeona Therapeutics Inc. May 3, 2024 @ 11:30 AM Abeona Therapeutics Announces Pricing of $75 Milli... Source: Abeona Therapeutics Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.63 $.19 $-1.16 Diluted EPS $-.63 $-.26 $-1.16 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -30.27M $ 7.41M $ -31.58M Operating Income / Loss $ -15.35M $ -17.86M $ -14.33M Cost of Revenue $ $ $ Net Cash Flow $ -18.7M $ 16.87M $ 3.09M PE Ratio     Splits Jul 05, 2022:   25:1 Oct 24, 2014:   50:1 Jun 05, 2006:   5:1